Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of DermatologyContinue reading
Tag Archives: Castle Biosciences
RiboMed launches improved prognostic multi biomarker epigenetic test for brain cancer
“The unparalleled sensitivity, accuracy, and reproducibility offered by the Abscription®-based G-CIMP test, coupled with its ability to efficiently assess multiple methylation biomarkers in FFPE patient samples, makes this the best in class option for prognostic glioma testing.”Continue reading